03:47 PM EST - Paladin Labs Inc. : has signed partnership deal with Stallergenes SA of France on Canadian development, promotion and distribution agreement for Oralair, allergen extract immunotherapy tablets. Canadian regulatory approval to be sought this year. Paladin Labs Inc.
shares T.PLB are trading ahead 24 cents at $10.69.
